Tatva Chintan Pharma Chem Limited IPO
Mainboard₹14,079 / 13 Shares
Tatva Chintan Pharma Chem Limited IPO Details
The Tatva Chintan Pharma Chem Limited IPO price band is set between ₹1073-1083 per equity share, with a face value of ₹10 per share. The issue is managed by Link Intime India Private Ltd, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 16 Jul, 2021 and closes on 20 Jul, 2021. Investors can check the allotment status on 26 Jul, 2021, while the listing date is tentatively scheduled for 29 Jul, 2021.
The total issue size is 500 Cr, aggregating up to . Stay tuned for the latest Tatva Chintan Pharma Chem Limited IPO review and GMP updates.
Tatva Chintan Pharma Chem Limited IPO Review, Rating & Analysis
Tatva Chintan Pharma Chem Limited IPO Review
NO REVIEWTatva Chintan Pharma Chem Limited IPO Rating
Tatva Chintan Pharma Chem Limited IPO Highlights
IPO Date
Jul 16, 2021 - Jul 20, 2021
Listing Date
29 Jul, 2021
Face Value
₹10 Per Equity Share
Price Band
₹1073-1083 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE, NSE
Tatva Chintan Pharma Chem Limited IPO Lot Size
The minimum market lot for Tatva Chintan Pharma Chem Limited IPO is 13 shares with an application amount of ₹14,079. Retail investors can apply for up to 14 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 13 | ₹14,079 |
| Retail (Max) | 14 | 182 | ₹1,97,106 |
| S-HNI (Min) | 15 | 195 | ₹2,11,185 |
| S-HNI (Max) | 71 | 923 | ₹9,99,609 |
| B-HNI (Min) | 72 | 936 | ₹10,13,688 |
Tatva Chintan Pharma Chem Limited IPO Timeline
Issue Price
₹1073-1083 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
Link Intime India Private LtdLead Manager
ICICI Securities Limited, JM Financial Consultants Private LimitedIssue Size
500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale)Tatva Chintan Pharma Chem Limited IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 21 | 314.80 | 306.29 | 52.26 | - | - | - |
| 31 Mar 20 | 248.94 | 264.62 | 37.79 | - | - | - |
| 31 Mar 19 | 187.51 | 206.8 | 20.54 | - | - | - |
| 31 Mar 18 | 143.72 | 137.29 | 12.29 | - | - | - |
All values are in ₹ Cr.
Promoters & Share Holding
Promoter(s) Name
- Ajaykumar Mansukhalal Patel
- Chintan Nitinkumar Shah
- Shekhar Rasiklal Somani
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 100% | 79.17% |
About Company
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Tatva Chintan Pharma Chem Limited IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 9,31,966 | 6,98,975 | 16,30,941 | 32,61,882 |
Day 1 -16-07-20 05:00 PM | 0.51 x | 1.13 | 8.25 x | 4.51 x |
Day 2 -19-07-20 05:00 PM | 1.97 x | 12.21 | 23.74 x | 15.05 x |
Day 3 -20-07-20 05:00 PM | 186.96 x | 516.99 | 35.67 x | 182.04 x |
26.10 times
Frequently Asked Questions about Tatva Chintan Pharma Chem Limited IPO IPO
When will Tatva Chintan Pharma Chem Limited IPO open for subscription?
The Tatva Chintan Pharma Chem Limited IPO opens on 16 Jul, 2021 and closes on 20 Jul, 2021.
What is the investors portion for Tatva Chintan Pharma Chem Limited IPO?
The investors' portion for QIB is 186.96 x, NII is 516.99, and Retail is 35.67 x.
How to apply for Tatva Chintan Pharma Chem Limited IPO?
You can apply for Tatva Chintan Pharma Chem Limited IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Tatva Chintan Pharma Chem Limited IPO?
The issue size of Tatva Chintan Pharma Chem Limited IPO is approx ₹500 Cr(225 Cr Fresh Issue + 275 Cr Offer for Sale) crores.
What is the price band of Tatva Chintan Pharma Chem Limited IPO?
The price band for Tatva Chintan Pharma Chem Limited IPO is ₹1073 to ₹1083 per equity share.
What is the lot size of Tatva Chintan Pharma Chem Limited IPO?
The minimum bid (lot size) for Tatva Chintan Pharma Chem Limited IPO is N/A shares with an investment of approx ₹14,079 .
What is the allotment date of Tatva Chintan Pharma Chem Limited IPO?
The allotment date for Tatva Chintan Pharma Chem Limited IPO is 26 Jul, 2021.
What is the listing date of Tatva Chintan Pharma Chem Limited IPO?
The listing date for Tatva Chintan Pharma Chem Limited IPO is expected to be 29 Jul, 2021.
What is the GMP of Tatva Chintan Pharma Chem Limited IPO?
The latest Grey Market Premium (GMP) for Tatva Chintan Pharma Chem Limited IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.